Medicine for treating acute myelitis and application thereof

A myelitis and drug technology, applied in the field of medicine, can solve side effects, quickly relieve the difficulty of acute myelitis and other problems, and achieve the effects of less side effects, enhanced immunity, and definite curative effect.

Pending Publication Date: 2021-09-24
THE PEOPLES HOSPITAL SHAANXI PROV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, the existing hormones used (such as methylprednisolone) can have serious side effects on the human...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating acute myelitis and application thereof
  • Medicine for treating acute myelitis and application thereof
  • Medicine for treating acute myelitis and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] (1) Experimental drugs:

[0024] Experimental group 1: 5g ganglioside, 1g vitamin B6 and 1g vitamin C were added to 100ml of 5% glucose solution to make injection;

[0025] Experimental group 2: 5g ganglioside, 2g vitamin B6 and 1g vitamin C were added to 100ml of 5% glucose solution to make injection;

[0026] Positive control group 1: 7g ganglioside was added to 100ml of 5% glucose solution to make injection;

[0027] Positive control group 2: 5g ganglioside, 1g vitamin B1 and 1g vitamin C were added to 100ml of 5% glucose solution to make injection;

[0028] Positive control group 3: 5g ganglioside, 1g vitamin B12 and 1g vitamin C were added to 100ml of 5% glucose solution to make injection;

[0029] Negative control group: 5% glucose solution.

[0030] (2) Modeling and administration methods:

[0031] Select 60 adult healthy Wistar rats of clean standard, male or female, weighing 250-300 g, anesthetized by intraperitoneal injection of 1% pentobarbital sodium (50...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine for treating acute myelitis and application thereof. The medicine composition takes ganglioside, vitamin B6 and vitamin C as active ingredients, and through scientific compatibility, the medicine composition can provide nutritional support for patients and enhance organism immunity. Compared with the existing medicine for treating spinal cord injury diseases, the medicine has the advantages of definite curative effect, high effect taking speed, small side effect and the like.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a medicine for treating acute myelitis and its application. Background technique [0002] Acute myelitis (acute myelitis) is a kind of paralysis, sensory disturbance and autonomy below the level of acute onset myelopathy, which may be caused by virus, bacterial infection, vaccine injection and other factors leading to spinal cord congestion, edema and nerve fiber demyelination. Neurological dysfunction is the main manifestation of spinal cord disease. The disease mostly occurs in young adults, and there is no gender difference. Symptoms of upper respiratory tract infection are often present several days or 12 weeks before the illness, and cold, overwork, trauma, etc. are often the triggers for the onset. The modern clinical treatment of this disease is mainly based on glucocorticoids, and better results can be achieved by cooperating with gamma globulin intravenous...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/7032A61P29/00A61P37/04A61P25/00A61P31/00A61K31/375A61K31/4415
CPCA61K31/7032A61K31/4415A61K31/375A61P29/00A61P37/04A61P25/00A61P31/00A61K2300/00
Inventor 陈晓莉张国平
Owner THE PEOPLES HOSPITAL SHAANXI PROV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products